Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3306446rdf:typepubmed:Citationlld:pubmed
pubmed-article:3306446lifeskim:mentionsumls-concept:C0024299lld:lifeskim
pubmed-article:3306446pubmed:issue4lld:pubmed
pubmed-article:3306446pubmed:dateCreated1987-10-22lld:pubmed
pubmed-article:3306446pubmed:abstractTextTwo cases of metastatic malignant lymphoma confined to the limbic-hypothalamic region are presented. The non-specific nature of the neurological symptoms associated with these lesions such as memory loss, impotence and confusion made neurological localization of the disease process difficult. While non-contrast computed tomography (CT) was unremarkable, contrast CT was diagnostic, showing bilateral homogenous enhancement of specific limbic-hypothalamic structures without significant mass effect. Since lymphomatous involvement of the limbic-hypothalamic area tends to be infiltrative without attendant mass effect, detection of metastasis may be elusive unless special attention is directed to this region. As lymphoma is often chemoresponsive and highly radiosensitive, early recognition of limbic-hypothalamic involvement of this disease is important.lld:pubmed
pubmed-article:3306446pubmed:languageenglld:pubmed
pubmed-article:3306446pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3306446pubmed:citationSubsetIMlld:pubmed
pubmed-article:3306446pubmed:statusMEDLINElld:pubmed
pubmed-article:3306446pubmed:issn0028-3940lld:pubmed
pubmed-article:3306446pubmed:authorpubmed-author:NakadaTTlld:pubmed
pubmed-article:3306446pubmed:authorpubmed-author:KweeI LILlld:pubmed
pubmed-article:3306446pubmed:authorpubmed-author:ArasakiKKlld:pubmed
pubmed-article:3306446pubmed:issnTypePrintlld:pubmed
pubmed-article:3306446pubmed:volume29lld:pubmed
pubmed-article:3306446pubmed:ownerNLMlld:pubmed
pubmed-article:3306446pubmed:authorsCompleteYlld:pubmed
pubmed-article:3306446pubmed:pagination389-92lld:pubmed
pubmed-article:3306446pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:3306446pubmed:meshHeadingpubmed-meshheading:3306446-...lld:pubmed
pubmed-article:3306446pubmed:meshHeadingpubmed-meshheading:3306446-...lld:pubmed
pubmed-article:3306446pubmed:meshHeadingpubmed-meshheading:3306446-...lld:pubmed
pubmed-article:3306446pubmed:meshHeadingpubmed-meshheading:3306446-...lld:pubmed
pubmed-article:3306446pubmed:meshHeadingpubmed-meshheading:3306446-...lld:pubmed
pubmed-article:3306446pubmed:meshHeadingpubmed-meshheading:3306446-...lld:pubmed
pubmed-article:3306446pubmed:meshHeadingpubmed-meshheading:3306446-...lld:pubmed
pubmed-article:3306446pubmed:meshHeadingpubmed-meshheading:3306446-...lld:pubmed
pubmed-article:3306446pubmed:year1987lld:pubmed
pubmed-article:3306446pubmed:articleTitleLimbic lymphoma.lld:pubmed
pubmed-article:3306446pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3306446pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:3306446pubmed:publicationTypeCase Reportslld:pubmed